Celiac Disease Linked to Increased Risk of Pneumococcal Infection

By August 15, 2017

After adjusting for socioeconomic index, diabetes, level of education, sex and age, an increased risk of pneumococcal infection among celiac disease patients was noted.

Efficacy of Killed Whole-Cell Oral Cholera Vaccine Examined

August 14, 2017

During the 2 years after vaccination the 2-dose efficacy estimates were similar, with estimates of 56 and 59% in the first and second year, respectively.

FDA Approves Concomitant Administration of Zostavax and Flu Vaccines

By August 09, 2017

Zostavax is a vaccine indicated for the prevention of herpes zoster (shingles) in adults aged ≥50 years.

Vaccine for Recurrent UTI Granted Fast Track Designation

By July 26, 2017

The vaccine consists of the FimH bacterial adhesion protein as well as a new adjuvant designed to induce an immune response to prevent bacterial colonization of the urinary tract.

Vaccine Regimens Generate Anti-HIV Immune Responses in Early-Stage Trial

By July 26, 2017

The early-stage clinical trial studied "mosaic" vaccines created to induce immune responses against various HIV subtypes responsible for infections across the world.

Vaccine Hesitancy Linked to Substantial Public Health Consequences

July 25, 2017

The researchers determined that just a 5% drop in measles, mumps, and rubella vaccine coverage would triple the number of measles cases in children aged 2 to 11 years nationally every year.

Seqirus Begins Shipping Flu Vaccines for 2017/18 Season

By July 21, 2017

Specific vaccines in the Seqirus portfolio for the upcoming flu season include Afluria Quadrivalent (ages ≥18 years), the egg-based quadrivalent influenza vaccine, and Afluria (ages ≥5 years) and Fluvirin (ages ≥4 years), the egg-based trivalent influenza vaccines.

Recall Announced for Meningitis Vaccine

By July 19, 2017

This recall is considered precautionary as the batch associated with the recall was subject to a "mechanical intervention executed during the aseptic filling operations, which is not supported by validation data."

Widespread Shipment of Fluzone Product Line Will Begin in Early August

By July 18, 2017

The Fluzone vaccines should not be given to any individual with a severe allergic reaction to any vaccine component, including eggs, egg products, thimerosol, or to a previous dose of any flu vaccine.

Many Parents Unsure About Teen Vaccine Schedules

By July 17, 2017

Surveyed parents reported that an appointment scheduled by the provider (44%), mentioning vaccination during an office visit by a clinician (40%), or a reminder sent by the clinician's office (11%) were the primary methods by which they were informed of the need for additional vaccines.

Gonorrhea Vaccine May Be One Step Closer to Reality

July 11, 2017

First time vaccine has shown any protection against gonorrhea, researchers report

Cancer Peptide Vaccine Designated Orphan Drug for MDS

By July 10, 2017

Data from a Phase 1/2 study in patients with MDS who had disease progression on or after first-line azacitidine treatment showed initial signs of clinical activity with DSP-7888, and that it was well tolerated in study patients.

Self-Administered 'Patch' Vaccines May Soon Become Reality

By June 28, 2017

The positive self-administration results indicate that the patch could have the potential to reduce the costs of vaccination as healthcare workers may not be needed to supervise the process.

Obesity May Increase Influenza Risk Among Vaccinated Patients

By June 27, 2017

The researchers assessed the relative risk for influenza and ILI on the basis of body mass index and determined seroconversion and seroprotection rates using pre-vaccination and 26-35 day post-vaccination serum samples.

CDC: Worldwide Containment of Poliovirus Nears Completion

June 27, 2017

In 2015, wild poliovirus type 2 was certified as eradicated, and the trivalent oral poliovirus vaccine (OPV) was replaced globally with a bivalent OPV containing Sabin poliovirus types 1 and 3.

Recombinant Flu Vaccine May Protect Seniors Better than Traditional Vaccine

By June 22, 2017

Flublok Quadrivalent, approved by the Food and Drug Administration (FDA) in October 2016, is a recombinant protein-based vaccine developed without the use of eggs.

Emergency Department Trends Revealed for Herpes Zoster-Related Visits

June 22, 2017

The researchers identified 1,350,957 emergency department visits for HZ from 2006 to 2013, representing 0.13% of all U.S. emergency department visits.

Shingrix Proves Noninferior to Current Zoster Vaccine in Study

By June 21, 2017

"[These results] indicate that Shingrix can be an option for adults over 50 years of age, who previously received the currently available vaccine and are seeking to benefit from revaccination with Shingrix, if recommended," said Dr. Thomas Breuer, SVP and CMO of GSK Vaccines.

Adolescent Immunization Initiative Puts Focus on Vaccines at 16 Years of Age

June 20, 2017

A subtle but significant change took place in the 2017 adolescent immunization schedule when the Advisory Committee on Immunization Practices (ACIP) created a separate column just for 16-year-olds.

Novel HIV Vaccine Shows High Immune Response Rate in Study

By May 24, 2017

Overall, 71 of 76 participants (93%) showed detectable CD4+ or CD8+ responses to at least one of the vaccine's four antigens.

Most Eligible U.S. Travelers Refuse Pre-Trip Measles Vaccine

May 16, 2017

A total of 40,810 pre-travel clinic visits were analyzed for measles vaccination, concern among patients.

ACIP Issues Recommendations for Cholera Vaccination

By May 11, 2017

The efficacy of Vaxchora was 90% among those challenged 10 days post-vaccination, and 80% among those challenged 3 months post-vaccination.

CDC: Tackling the Yellow Fever Vaccine Supply Shortage in U.S.

By April 28, 2017

The diminishing supply of YF-VAX started in November 2015 as Sanofi Pasteur was shifting to a newer production facility set to open in 2018.

Researchers Predict Next 7 Great Advances in Pediatric Healthcare

April 24, 2017

The researchers noted that how it is an extraordinary time of new research tools that include electronic health records, technological ability to manage big data, and new functional and structural imaging modalities.

Complications After Mumps Outbreak Investigated

By April 13, 2017

Complications may also occur at different times throughout the illness even without parotitis.

Does IBD Impact Response to Booster Pertussis Dose?

By April 12, 2017

The data showed no difference in the rates of adequate vaccine response between the 4 study groups (P=0.11). Patients with IBD taking immunosuppressive therapy did not differ from those not taking immunosuppressive therapy (90.6% vs. 88.2%; P=0.37).

CDC: Nearly Half of U.S. Population Under 60 Has HPV

April 07, 2017

CDC researchers found that 45.2% of men and 39.9% of women were infected with any genital HPV in 2013 to 2014, while 25.1% of men and 20.4% of women were infected with high-risk genital HPV.

Extended Shelf Life Approved for Egg-Free Flu Vaccine

By April 05, 2017

Flublok Quadrivalent was approved by the FDA in October 2016 for use in adults aged >18 years.

Maternal Tdap Vaccination Highly Protective Against Infant Pertussis

By April 03, 2017

Researchers from Kaiser Permanente Vaccine Study Center conducted a retrospective cohort study of infants born at Kaiser Permanente Northern California from 2010-2015 to estimate the efficacy of maternal pertussis vaccination.

Impact of Vaccination Measured Against Flu-Linked Pediatric Deaths

April 03, 2017

The researchers found that there were 358 laboratory-confirmed influenza-associated pediatric deaths among children aged 6 months through 17 years from July 2010 through June 2014.